SANJIVINPharmaceuticals
Sanjivani Paranteral Ltd — Quarterly Results & Earnings
₹132.75
-4.83%
Profit Growth YoY-28.70%Latest quarter
Sales Growth YoY-14.51%Latest quarter
Sales CAGR 5Y33.89%5 year compound
Profit CAGR 5Y46.45%5 year compound
📋
Quarterly Performance
YoY Profit Growth-28.70%
🔴 Significant decline
YoY Sales Growth-14.51%
🔴 Significant decline
OPM 5Y Average
14.49%Operating profit margin
EPS Growth 5Y
34.19%Interest Coverage
15.64Higher = safer debt servicing
ROE
24.58%ROCE
30.21%💡
Growth Analysis
Sanjivani Paranteral Ltd reported YoY profit growth of -28.70% and revenue growth of -14.51% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 33.89% and profits at 46.45% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Sanjivani Paranteral Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.